Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1997 2
1998 1
1999 3
2001 1
2003 2
2004 3
2005 4
2006 3
2007 2
2008 4
2009 5
2010 5
2011 3
2012 4
2013 4
2014 1
2015 2
2016 4
2017 5
2018 4
2019 3
2020 2
2021 5
2022 5
2023 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, García-Sancho AM, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G. Morschhauser F, et al. J Clin Oncol. 2022 Oct 1;40(28):3239-3245. doi: 10.1200/JCO.22.00843. Epub 2022 Aug 10. J Clin Oncol. 2022. PMID: 35947804 Free PMC article.
Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.The RELEVANCE trial (ClinicalTrials.gov identifier: NCT01650701) showed that
Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, f
Treating relapsed follicular lymphoma.
Erblich T, Montoto S. Erblich T, et al. Expert Rev Hematol. 2018 May;11(5):403-410. doi: 10.1080/17474086.2018.1453801. Epub 2018 Mar 20. Expert Rev Hematol. 2018. PMID: 29542329 Review.
Advanced follicular lymphoma (FL) remains an incurable disease, at least with conventional therapy. ...In this context, therapeutic decisions for individual patients in a disease which is increasingly becoming a chronic condition require a tailored approach i
Advanced follicular lymphoma (FL) remains an incurable disease, at least with conventional therapy. ...In this context,
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA. Kochenderfer JN, et al. Blood. 2010 Nov 18;116(20):4099-102. doi: 10.1182/blood-2010-04-281931. Epub 2010 Jul 28. Blood. 2010. PMID: 20668228 Free PMC article. Clinical Trial.
Adoptive transfer of genetically modified T cells is an attractive approach for generating antitumor immune responses. We treated a patient with advanced follicular lymphoma by administering a preparative chemotherapy regimen followed by autologous T cells ge …
Adoptive transfer of genetically modified T cells is an attractive approach for generating antitumor immune responses. We treated a patient …
Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis.
Al Khabori M, de Almeida JR, Guyatt GH, Kuruvilla J, Crump M. Al Khabori M, et al. J Natl Cancer Inst. 2012 Jan 4;104(1):18-28. doi: 10.1093/jnci/djr450. Epub 2011 Dec 21. J Natl Cancer Inst. 2012. PMID: 22190633 Review.
BACKGROUND: The impact of high-dose therapy and autologous stem cell transplantation (ASCT) vs conventional-dose chemotherapy in the initial management of adults with advanced follicular lymphoma (FL) on overall survival remains uncertain. We performed a syst …
BACKGROUND: The impact of high-dose therapy and autologous stem cell transplantation (ASCT) vs conventional-dose chemotherapy in the initial …
Hematopoietic stem cell transplantation for follicular lymphoma: optimal timing and indication.
Kim SW. Kim SW. J Clin Exp Hematop. 2014;54(1):39-47. doi: 10.3960/jslrt.54.39. J Clin Exp Hematop. 2014. PMID: 24942945 Free article. Review.
The definitive management of advanced follicular lymphoma (FL) remains controversial due to various treatment options, including watchful waiting, single-agent or combination chemotherapy, monoclonal antibody, and radioimmunotherapy. ...On the basis of result …
The definitive management of advanced follicular lymphoma (FL) remains controversial due to various treatment options, …
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Watanabe T, Matsuno Y, Wakabayashi M, Maruyama D, Yamamoto K, Kubota N, Shimada K, Asagoe K, Yamaguchi M, Ando K, Ogura M, Kuroda J, Suehiro Y, Tsukasaki K, Tobinai K, Nagai H. Watanabe T, et al. Hematol Oncol. 2024 May;42(3):e3272. doi: 10.1002/hon.3272. Hematol Oncol. 2024. PMID: 38595316 Clinical Trial.
Follicular lymphoma (FL) is an indolent lymphoma that becomes aggressive due to histological transformation (HT), leading to reduced survival. Patients with FL have different clinical courses and various treatment options. Some patients exhibit shorter survival and experie …
Follicular lymphoma (FL) is an indolent lymphoma that becomes aggressive due to histological transformation (HT), leading to reduced surviva …
75 results